<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-03-25" modified="2020-10-07" version="167">
<accession>O95997</accession>
<name>PTTG1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Securin</fullName>
</recommendedName>
<alternativeName>
<fullName>Esp1-associated protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Pituitary tumor-transforming gene 1 protein</fullName>
<shortName>Tumor-transforming protein 1</shortName>
<shortName>hPTTG</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">PTTG1</name>
<name type="synonym">EAP1</name>
<name type="synonym">PTTG</name>
<name type="synonym">TUTR1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Oncogene" volume="17" first="2187" last="2193">
<title>hPTTG, a human homologue of rat PTTG, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG.</title>
<authorList>
<person name="Dominguez A."/>
<person name="Ramos-Morales F."/>
<person name="Romero F."/>
<person name="Rios R.M."/>
<person name="Dreyfus F."/>
<person name="Tortolero M."/>
<person name="Pintor-Toro J.A."/>
</authorList>
<dbReference type="PubMed" id="9811450"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202140"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Thymus</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="1998-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mu Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Pituitary adenoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="Cytogenet. Cell Genet." volume="84" first="211" last="216">
<title>Molecular cloning and characterization of the tumor transforming gene (TUTR1): a novel gene in human tumorigenesis.</title>
<authorList>
<person name="Kakar S.S."/>
<person name="Jennes L."/>
</authorList>
<dbReference type="PubMed" id="10393434"/>
<dbReference type="DOI" id="10.1159/000015261"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>DISEASE</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1999" name="Gene" volume="240" first="317" last="324">
<title>Molecular cloning, genomic organization, and identification of the promoter for the human pituitary tumor transforming gene (PTTG).</title>
<authorList>
<person name="Kakar S.S."/>
</authorList>
<dbReference type="PubMed" id="10580151"/>
<dbReference type="DOI" id="10.1016/s0378-1119(99)00446-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="Mol. Endocrinol." volume="13" first="156" last="166">
<title>Structure, expression, and function of human pituitary tumor-transforming gene (PTTG).</title>
<authorList>
<person name="Zhang X."/>
<person name="Horwitz G.A."/>
<person name="Prezant T.R."/>
<person name="Valentini A."/>
<person name="Nakashima M."/>
<person name="Bronstein M.D."/>
<person name="Melmed S."/>
</authorList>
<dbReference type="PubMed" id="9892021"/>
<dbReference type="DOI" id="10.1210/mend.13.1.0225"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>DISEASE</scope>
<scope>MUTAGENESIS OF PRO-163 AND 170-PRO--PRO-173</scope>
<source>
<tissue>Fetal liver</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="J. Clin. Endocrinol. Metab." volume="84" first="761" last="767">
<title>Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.</title>
<authorList>
<person name="Zhang X."/>
<person name="Horwitz G.A."/>
<person name="Heaney A.P."/>
<person name="Nakashima M."/>
<person name="Prezant T.R."/>
<person name="Bronstein M.D."/>
<person name="Melmed S."/>
</authorList>
<dbReference type="PubMed" id="10022450"/>
<dbReference type="DOI" id="10.1210/jcem.84.2.5432"/>
</citation>
<scope>DISEASE</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1999" name="Science" volume="285" first="418" last="422">
<title>Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis.</title>
<authorList>
<person name="Zou H."/>
<person name="McGarry T.J."/>
<person name="Bernal T."/>
<person name="Kirschner M.W."/>
</authorList>
<dbReference type="PubMed" id="10411507"/>
<dbReference type="DOI" id="10.1126/science.285.5426.418"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ESPL1</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF ARG-61 AND LEU-64</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="19422" last="19427">
<title>A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product.</title>
<authorList>
<person name="Chien W."/>
<person name="Pei L."/>
</authorList>
<dbReference type="PubMed" id="10781616"/>
<dbReference type="DOI" id="10.1074/jbc.m910105199"/>
</citation>
<scope>INTERACTION WITH PTTG1IP</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="Nucleic Acids Res." volume="29" first="1300" last="1307">
<title>Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase.</title>
<authorList>
<person name="Romero F."/>
<person name="Multon M.C."/>
<person name="Ramos-Morales F."/>
<person name="Dominguez A."/>
<person name="Bernal J.A."/>
<person name="Pintor-Toro J.A."/>
<person name="Tortolero M."/>
</authorList>
<dbReference type="PubMed" id="11238996"/>
<dbReference type="DOI" id="10.1093/nar/29.6.1300"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH KU</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="Cell" volume="105" first="445" last="457">
<title>Securin is required for chromosomal stability in human cells.</title>
<authorList>
<person name="Jallepalli P.V."/>
<person name="Waizenegger I.C."/>
<person name="Bunz F."/>
<person name="Langer S."/>
<person name="Speicher M.R."/>
<person name="Peters J.-M."/>
<person name="Kinzler K.W."/>
<person name="Vogelstein B."/>
<person name="Lengauer C."/>
</authorList>
<dbReference type="PubMed" id="11371342"/>
<dbReference type="DOI" id="10.1016/s0092-8674(01)00340-3"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="J. Clin. Endocrinol. Metab." volume="86" first="867" last="874">
<title>Human pituitary tumor-transforming gene induces angiogenesis.</title>
<authorList>
<person name="Ishikawa H."/>
<person name="Heaney A.P."/>
<person name="Yu R."/>
<person name="Horwitz G.A."/>
<person name="Melmed S."/>
</authorList>
<dbReference type="PubMed" id="11158059"/>
<dbReference type="DOI" id="10.1210/jcem.86.2.7184"/>
</citation>
<scope>DISEASE</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="Nat. Genet." volume="32" first="306" last="311">
<title>Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis.</title>
<authorList>
<person name="Bernal J.A."/>
<person name="Luna R."/>
<person name="Espina A."/>
<person name="Lazaro I."/>
<person name="Ramos-Morales F."/>
<person name="Romero F."/>
<person name="Arias C."/>
<person name="Silva A."/>
<person name="Tortolero M."/>
<person name="Pintor-Toro J.A."/>
</authorList>
<dbReference type="PubMed" id="12355087"/>
<dbReference type="DOI" id="10.1038/ng997"/>
</citation>
<scope>INTERACTION WITH TP53</scope>
<scope>FUNCTION IN TP53 PATHWAY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Oncogene" volume="19" first="403" last="409">
<title>Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product.</title>
<authorList>
<person name="Ramos-Morales F."/>
<person name="Dominguez A."/>
<person name="Romero F."/>
<person name="Luna R."/>
<person name="Multon M.-C."/>
<person name="Pintor-Toro J.A."/>
<person name="Tortolero M."/>
</authorList>
<dbReference type="PubMed" id="10656688"/>
<dbReference type="DOI" id="10.1038/sj.onc.1203320"/>
</citation>
<scope>PHOSPHORYLATION AT SER-165</scope>
<scope>MUTAGENESIS OF SER-165</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Cell" volume="133" first="653" last="665">
<title>Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex.</title>
<authorList>
<person name="Jin L."/>
<person name="Williamson A."/>
<person name="Banerjee S."/>
<person name="Philipp I."/>
<person name="Rape M."/>
</authorList>
<dbReference type="PubMed" id="18485873"/>
<dbReference type="DOI" id="10.1016/j.cell.2008.04.012"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DOMAIN TEK-BOX</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<comment type="function">
<text evidence="3 6 7 8">Regulatory protein, which plays a central role in chromosome stability, in the p53/TP53 pathway, and DNA repair. Probably acts by blocking the action of key proteins. During the mitosis, it blocks Separase/ESPL1 function, preventing the proteolysis of the cohesin complex and the subsequent segregation of the chromosomes. At the onset of anaphase, it is ubiquitinated, conducting to its destruction and to the liberation of ESPL1. Its function is however not limited to a blocking activity, since it is required to activate ESPL1. Negatively regulates the transcriptional activity and related apoptosis activity of TP53. The negative regulation of TP53 may explain the strong transforming capability of the protein when it is overexpressed. May also play a role in DNA repair via its interaction with Ku, possibly by connecting DNA damage-response pathways with sister chromatid separation.</text>
</comment>
<comment type="subunit">
<text evidence="2 3 5 6 8">Interacts with RPS10 and DNAJA1 (By similarity). Interacts with the caspase-like ESPL1, and prevents its protease activity probably by covering its active site. Interacts with TP53 and blocks its activity probably by blocking its binding to DNA. Interacts with the Ku 70 kDa subunit of ds-DNA kinase. Interacts with PTTG1IP.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="10">Expressed at low level in most tissues, except in adult testis, where it is highly expressed. Overexpressed in many patients suffering from pituitary adenomas, primary epithelial neoplasias, and esophageal cancer.</text>
</comment>
<comment type="developmental stage">
<text>Low level during G1 and S phases. Peaks at M phase. During anaphase, it is degraded.</text>
</comment>
<comment type="domain">
<text evidence="2">The N-terminal destruction box (D-box) acts as a recognition signal for degradation via the ubiquitin-proteasome pathway.</text>
</comment>
<comment type="domain">
<text evidence="9">The TEK-boxes are required for 'Lys-11'-linked ubiquitination and facilitate the transfer of the first ubiquitin and ubiquitin chain nucleation. TEK-boxes may direct a catalytically competent orientation of the UBE2C/UBCH10-ubiquitin thioester with the acceptor lysine residue.</text>
</comment>
<comment type="PTM">
<text evidence="4">Phosphorylated at Ser-165 by CDK1 during mitosis.</text>
</comment>
<comment type="PTM">
<text evidence="4">Phosphorylated in vitro by ds-DNA kinase.</text>
</comment>
<comment type="PTM">
<text evidence="3 9">Ubiquitinated through 'Lys-11' linkage of ubiquitin moieties by the anaphase promoting complex (APC) at the onset of anaphase, conducting to its degradation. 'Lys-11'-linked ubiquitination is mediated by the E2 ligase UBE2C/UBCH10.</text>
</comment>
<comment type="similarity">
<text evidence="12">Belongs to the securin family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PTTG1ID41943ch5q35.html"/>
</comment>
<dbReference type="EMBL" id="AJ223953">
<property type="protein sequence ID" value="CAA11683.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF095287">
<property type="protein sequence ID" value="AAC64409.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF075242">
<property type="protein sequence ID" value="AAD19335.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167564">
<property type="protein sequence ID" value="AAF06995.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167560">
<property type="protein sequence ID" value="AAF06995.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167561">
<property type="protein sequence ID" value="AAF06995.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167562">
<property type="protein sequence ID" value="AAF06995.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167563">
<property type="protein sequence ID" value="AAF06995.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4353.1"/>
<dbReference type="RefSeq" id="NP_001269311.1">
<property type="nucleotide sequence ID" value="NM_001282382.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001269312.1">
<property type="nucleotide sequence ID" value="NM_001282383.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004210.1">
<property type="nucleotide sequence ID" value="NM_004219.3"/>
</dbReference>
<dbReference type="SMR" id="O95997"/>
<dbReference type="BioGRID" id="114663">
<property type="interactions" value="108"/>
</dbReference>
<dbReference type="CORUM" id="O95997"/>
<dbReference type="DIP" id="DIP-56460N"/>
<dbReference type="ELM" id="O95997"/>
<dbReference type="IntAct" id="O95997">
<property type="interactions" value="19"/>
</dbReference>
<dbReference type="MINT" id="O95997"/>
<dbReference type="STRING" id="9606.ENSP00000377536"/>
<dbReference type="iPTMnet" id="O95997"/>
<dbReference type="PhosphoSitePlus" id="O95997"/>
<dbReference type="BioMuta" id="PTTG1"/>
<dbReference type="EPD" id="O95997"/>
<dbReference type="jPOST" id="O95997"/>
<dbReference type="MassIVE" id="O95997"/>
<dbReference type="PaxDb" id="O95997"/>
<dbReference type="PeptideAtlas" id="O95997"/>
<dbReference type="PRIDE" id="O95997"/>
<dbReference type="ProteomicsDB" id="51174"/>
<dbReference type="Antibodypedia" id="1853">
<property type="antibodies" value="411 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="9232"/>
<dbReference type="Ensembl" id="ENST00000352433">
<property type="protein sequence ID" value="ENSP00000344936"/>
<property type="gene ID" value="ENSG00000164611"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000393964">
<property type="protein sequence ID" value="ENSP00000377536"/>
<property type="gene ID" value="ENSG00000164611"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000520452">
<property type="protein sequence ID" value="ENSP00000430642"/>
<property type="gene ID" value="ENSG00000164611"/>
</dbReference>
<dbReference type="GeneID" id="9232"/>
<dbReference type="KEGG" id="hsa:9232"/>
<dbReference type="CTD" id="9232"/>
<dbReference type="DisGeNET" id="9232"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000164611.12"/>
<dbReference type="GeneCards" id="PTTG1"/>
<dbReference type="HGNC" id="HGNC:9690">
<property type="gene designation" value="PTTG1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000164611">
<property type="expression patterns" value="Tissue enhanced (blood, testis)"/>
</dbReference>
<dbReference type="MIM" id="604147">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O95997"/>
<dbReference type="OpenTargets" id="ENSG00000164611"/>
<dbReference type="PharmGKB" id="PA34033"/>
<dbReference type="eggNOG" id="ENOG502S2GG">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000009693"/>
<dbReference type="HOGENOM" id="CLU_1363209_0_0_1"/>
<dbReference type="InParanoid" id="O95997"/>
<dbReference type="KO" id="K06635"/>
<dbReference type="OMA" id="SWESNLL"/>
<dbReference type="OrthoDB" id="1296347at2759"/>
<dbReference type="PhylomeDB" id="O95997"/>
<dbReference type="TreeFam" id="TF330797"/>
<dbReference type="PathwayCommons" id="O95997"/>
<dbReference type="Reactome" id="R-HSA-174154">
<property type="pathway name" value="APC/C:Cdc20 mediated degradation of Securin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-174178">
<property type="pathway name" value="APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2467813">
<property type="pathway name" value="Separation of Sister Chromatids"/>
</dbReference>
<dbReference type="SIGNOR" id="O95997"/>
<dbReference type="BioGRID-ORCS" id="9232">
<property type="hits" value="282 hits in 875 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PTTG1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="PTTG1"/>
<dbReference type="GenomeRNAi" id="9232"/>
<dbReference type="Pharos" id="O95997">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O95997"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="O95997">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000164611">
<property type="expression patterns" value="Expressed in secondary oocyte and 208 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O95997">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O95997">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0004869">
<property type="term" value="F:cysteine-type endopeptidase inhibitor activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017124">
<property type="term" value="F:SH3 domain binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0031145">
<property type="term" value="P:anaphase-promoting complex-dependent catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0051276">
<property type="term" value="P:chromosome organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045143">
<property type="term" value="P:homologous chromosome segregation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:2000816">
<property type="term" value="P:negative regulation of mitotic sister chromatid separation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006511">
<property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="DisProt" id="DP00521"/>
<dbReference type="InterPro" id="IPR006940">
<property type="entry name" value="Securin_separation_inhibitor"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10418">
<property type="entry name" value="PTHR10418"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04856">
<property type="entry name" value="Securin"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0159">Chromosome partition</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0498">Mitosis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0729">SH3-binding</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="1">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Securin" id="PRO_0000206361">
<location>
<begin position="2"/>
<end position="202"/>
</location>
</feature>
<feature type="short sequence motif" description="D-box">
<location>
<begin position="61"/>
<end position="64"/>
</location>
</feature>
<feature type="short sequence motif" description="TEK-box 1">
<location>
<begin position="71"/>
<end position="73"/>
</location>
</feature>
<feature type="short sequence motif" description="TEK-box 2">
<location>
<begin position="94"/>
<end position="96"/>
</location>
</feature>
<feature type="short sequence motif" description="SH3-binding">
<location>
<begin position="163"/>
<end position="173"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="1">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK1" evidence="4">
<location>
<position position="165"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ubiquitination and subsequent degradation; when associated with A-64." evidence="3">
<original>R</original>
<variation>A</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ubiquitination and subsequent degradation; when associated with A-61." evidence="3">
<original>L</original>
<variation>A</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces transforming capability; when associated with L-170; A-172 and L-173." evidence="11">
<original>P</original>
<variation>A</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="4">
<original>S</original>
<variation>A</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces transforming capability; when associated with A-163." evidence="11">
<original>PSPP</original>
<variation>LSAL</variation>
<location>
<begin position="170"/>
<end position="173"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10411507"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10656688"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10781616"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11238996"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11371342"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12355087"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18485873"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9811450"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9892021"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000305"/>
<sequence length="202" mass="22024" checksum="5F4740619AB8856F" modified="1999-05-01" version="1">MATLIYVDKENGEPGTRVVAKDGLKLGSGPSIKALDGRSQVSTPRFGKTFDAPPALPKATRKALGTVNRATEKSVKTKGPLKQKQPSFSAKKMTEKTVKAKSSVPASDDAYPEIEKFFPFNPLDFESFDLPEEHQIAHLPLSGVPLMILDEERELEKLFQLGPPSPVKMPSPPWESNLLQSPSSILSTLDVELPPVCCDIDI</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

